Drug Database
AC

aciclovir + hydrocortisone (Xerese / Xerclear / Lipsovir)

✓ Approved

Lapidot Medical · NR3C1 · 小分子

什么是 aciclovir + hydrocortisone?

aciclovir + hydrocortisone 是一种小分子,由Lapidot Medical研发。该药已获批,用于治疗相关适应症,给药途径:Topical。

药物档案

商品名Xerese, Xerclear, Lipsovir
公司Lapidot Medical
药物类别小分子
分子靶点NR3C1, ,
给药途径Topical
状态Approved

作用机制

分子靶点

aciclovir + hydrocortisone 作用于 3 个分子靶点:

NR3C1nuclear receptor subfamily 3 group C member 1 (GR, GCCR)
(UL30)
(UL30)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

aciclovir + hydrocortisone 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Congenital, familial and genetic disordersCongenital herpes simplex infection✓ Approved

相关研究文献

PubMedJCEM case reports2026-11-18

Thyroid storm induced by palpation thyroiditis after subtotal parathyroidectomy for lithium-induced hyperparathyroidism.

Elamin Mohamed M, Mohamed Sanas S, Kaplan Felicity F, Patel Anant A et al.

Palpation thyroiditis is an inflammatory condition of the thyroid gland that may occur following mechanical manipulation, particularly during parathyroid surgery. While postoperative biochemical thyrotoxicosis is relatively common, most patients remain asymptomatic, and severe presentations such as thyroid storm are rare. We report a 52-year-old man with primary hyperparathyroidism, likely lithium-induced, who underwent subtotal parathyroidectomy. His immediate postoperative course was uneventful; however, on postoperative day 3, he developed anterior neck swelling, followed by systemic symptoms including tachycardia, tremor, and fatigue by postoperative day 5. Biochemical findings confirmed severe thyrotoxicosis, and imaging demonstrated inflammatory swelling and edema around the thyroid without abscess formation. Initial management with propranolol and antibiotics resulted in transient clinical improvement. On postoperative day 9, the patient deteriorated with confusion, pyrexia, and worsening tachycardia, necessitating intensive care unit admission, where a diagnosis of thyroid storm was established. Management included intubation, carbimazole, propranolol, hydrocortisone, and cholestyramine, with discontinuation of lithium therapy. Thyroid function normalized within weeks, with sustained euthyroidism at 1-year follow-up. This case highlights thyroid storm as a rare but serious complication of palpation thyroiditis following parathyroid surgery and emphasizes the importance of early recognition and appropriate supportive management.

PMID 43047271
阅读全文 →
PubMedClinical medicine insights. Endocrinology and diabetes2026-11-18

Isolated Adrenocorticotropic Hormone Deficiency Secondary to Pembrolizumab-Induced Hypophysitis: A Case of Life-Threatening Adrenal Crisis in a Patient With Metastatic Melanoma.

Sherzodbek Tashbaev T, o'g'li Mamatov Hurshidbek Mirzakamol MHM, Mutalipov Azizbek A, Eshqobilov Ozodbek O et al.

Immune checkpoint inhibitors, particularly programmed cell death protein 1 (PD-1) inhibitors, can cause endocrine immune-related adverse events, including hypophysitis and secondary adrenal insufficiency. Isolated adrenocorticotropic hormone (ACTH) deficiency is uncommon but may present as a life-threatening adrenal crisis. We report the case of a 65-year-old man with stage IV BRAF wild-type metastatic melanoma receiving pembrolizumab who presented with profound fatigue, nausea, vomiting, weight loss, orthostatic dizziness, and hypotension. Laboratory evaluation revealed severe hyponatremia, mild hyperkalemia, hypoglycemia, and acute kidney injury. Serum cortisol was 2.1 µg/dL with an inappropriately low ACTH concentration of <5 pg/mL. A conventional 250 µg cosyntropin (Synacthen) stimulation test demonstrated an inadequate cortisol response, while other pituitary axes remained preserved. Pituitary magnetic resonance imaging showed mild enlargement and stalk thickening, consistent with hypophysitis. Intravenous hydrocortisone and fluid resuscitation rapidly restored hemodynamic and metabolic stability. At 6 months, ACTH remained <5 pg/mL, with persistent isolated corticotroph deficiency. Pembrolizumab-associated isolated ACTH deficiency should be considered when patients develop unexplained constitutional symptoms, hypotension, hyponatremia, or hypoglycemia. Prompt cortisol and ACTH assessment and glucocorticoid treatment are essential to prevent morbidity and mortality.

PMID 43048149
阅读全文 →
PubMedCureus2026-11-18

Lipoid Congenital Adrenal Hyperplasia Due to Steroidogenic Acute Regulatory Protein (StAR) Deficiency in a 46,XY Child With a Female Phenotype: A Case Report.

Vega Gutiérrez Maria Margarita MM, Ramírez Pertuz Daniela D, Silva Oviedo Nelly N, Awadalla Gabrial Shokery Salieb SS et al.

Primary adrenal insufficiency in childhood is frequently associated with inherited disorders. Lipoid congenital adrenal hyperplasia due to steroidogenic acute regulatory protein (StAR) deficiency is a rare disorder characterized by impaired mitochondrial cholesterol transfer and deficient adrenal and gonadal steroidogenesis. We report a five-year-old child raised as a girl who had been diagnosed with primary adrenal insufficiency at three months of age and was receiving hydrocortisone and fludrocortisone. Physical examination showed female-appearing external genitalia without virilization and Tanner stage I development. Biochemical evaluation demonstrated markedly elevated adrenocorticotropic hormone with profoundly low morning cortisol and globally reduced steroidogenesis, including low 17-hydroxyprogesterone, androstenedione, dehydroepiandrosterone sulfate, and free testosterone. Karyotyping revealed 46,XY. Anti-Müllerian hormone and inhibin B concentrations were compatible with preserved Sertoli cell secretory activity and supported the presence of testicular tissue despite severely impaired androgen production. A contrast-enhanced abdominal and pelvic magnetic resonance imaging study was subsequently re-evaluated in the picture archiving and communication system by an expert radiologist. Targeted review identified structures compatible with bilateral undescended testes, with the right probable gonad in the inguinal canal and the left probable gonad in the abdominal cavity. Magnetic resonance imaging and transabdominal ultrasonography also demonstrated a tubular structure posterior to the bladder that was considered compatible with a rudimentary vaginal canal; no definite uterine structure was identified on targeted review. Molecular testing identified a homozygous pathogenic truncating variant in STAR (NM_000349.3:c.577C>T; p.Arg193*), establishing the diagnosis of lipoid congenital adrenal hyperplasia due to StAR deficiency. This case highlights the value of integrating steroid profiles, cytogenetic findings, Sertoli cell biomarkers, molecular testing, and expert imaging review in children with primary adrenal insufficiency and 46,XY differences of sex development.

PMID 43048701
阅读全文 →
PubMedZoological research2026-11-18

Glucocorticoid signaling is required for fatty acid β-oxidation (FAO) via transcriptional regulation of carnitine palmitoyltransferase 1b ( cpt1b) in zebrafish.

Zhang Yuqing Y, Shi Shengchi S, Li Xi X, Shi Chuang C et al.

Glucocorticoid (GC) signaling via the glucocorticoid receptor (Gr) is crucial for vertebrate nutrient metabolism, but its regulatory role in lipid catabolism and the underlying mechanism remain poorly understood. In this study, three hypocortisolism models of proopiomelanocortin a ( pomca) -/-, steroidogenic acute regulatory protein ( star) -/-, and cytochrome P450 family 17 subfamily a 2 ( cyp17a2) -/- zebrafish, and one glucocorticoid resistance model of gr -/- zebrafish were used to investigate the role of GC signaling in vertebrate lipid metabolism. Similar features of remodeled energy homeostasis, including increased fat deposition and enhanced glucose utilization, were observed in star -/-, cyp17a2 -/-, and gr -/- zebrafish. Among the differentially expressed genes (DEGs) in the liver, carnitine palmitoyltransferase 1b ( cpt1b) was identified as a shared downregulated gene in star -/-, cyp17a2 -/-, and gr -/- fish, compared to their respective control siblings. Hydrocortisone administration restored the reduced fatty acid β-oxidation (FAO) activity and rescued the downregulated hepatic and muscular expression of cpt1b in star -/- and cyp17a2 -/- fish, but not in gr -/- fish. Furthermore, we demonstrated that GC could activate cpt1b expression by acting on its proximal promoter region via Gr. However, when fold-change values were calculated for all four mutant models relative to their respective control siblings, pomca -/- fish exhibited the greatest relative increase in testosterone levels, but the smallest reductions in cortisol levels and cpt1b expression. Consequently, unlike the other three fish models with impaired GC signaling, no adiposity was observed in pomca -/- fish. Overall, our results suggest that GC signaling enhances FAO by promoting cpt1b expression, and the development of obesity due to impaired GC signaling depends on accompanying plasma steroid hormone profiles in zebrafish.

PMID 43046729
阅读全文 →
PubMedFrontiers in neurology2026-11-17

Perioperative hydrocortisone for modulating stress and inflammation after microvascular decompression for hemifacial spasm: a single-center, randomized, assessor-blinded, controlled trial protocol.

Yu Renchao R, Xu Yinfu Y, Wang Jing J, Liu Tao T et al.

Microvascular decompression (MVD) for hemifacial spasm triggers substantial perioperative stress and inflammatory responses that may contribute to early postoperative symptoms and potentially influence long-term surgical outcomes. Perioperative corticosteroids can modulate these responses, but their efficacy and safety in this specific neurosurgical population remain inadequately characterized. This trial aims to evaluate whether short-course perioperative hydrocortisone reduces early postoperative symptom burden and to explore its effects on biomarker dynamics and long-term efficacy. This single-center, randomized, assessor-blinded, controlled trial will enroll 100 patients aged 18-70 years undergoing elective MVD for primary hemifacial spasm. Participants will be allocated 1:1 to receive either intravenous hydrocortisone (100 mg at induction, then days 1-2) or matching placebo. Primary outcomes are mean postoperative headache intensity (visual analogue scale, days 1-3) and 72-h cumulative rescue opioid consumption (oral morphine milligram equivalents). Secondary outcomes include recovery parameters, postoperative symptoms, and inflammatory biomarkers (interleukin-6, C-reactive protein, S100B), with serum cortisol reported only as a descriptive drug exposure variable. Long-term hemifacial spasm control and quality of life at 6 months will be explored. Safety monitoring includes infection, hyperglycemia, and psychiatric symptoms through 30 days. Intention-to-treat analysis will use Bonferroni-adjusted α = 0.025 for primary outcomes. The protocol has been approved by the Medical Ethics Committee of the Second People's Hospital of Liaocheng (Approval Number: [2025] Ethical Review No. (090), date of approval: 31 December 2025). The trial was prospectively registered in the Chinese Clinical Trial Registry (ChiCTR2600117513) on 26 January 2026, and recruitment of the first participant has not yet commenced. All participants will provide written informed consent. Results will be disseminated through peer-reviewed publications and conference presentations regardless of findings. https://www.chictr.org.cn/, ChiCTR2600117513.

PMID 43041386
阅读全文 →
PubMedEuropean journal of endocrinology2026-11-16

Symptoms of glucocorticoid-induced adrenal insufficiency - a systematic evaluation of clinician- and patient-reported symptoms and their significance for patients' decisions to take hydrocortisone stress doses.

Bjergstrøm Marie Louise Lund MLL, Boesen Victor Brun VB, Tei Randi Maria Hanghøj RMH, Al-Jorani Hajir H et al.

Glucocorticoid-induced adrenal insufficiency (GIAI) is a common, distinct form of adrenal insufficiency, yet its symptom profile remains poorly characterized. We systematically evaluated clinician- and patient-reported symptoms and the significance patients ascribe to them as indicators of a need for hydrocortisone stress doses. Mixed-methods sequential survey and interview study. Endocrinologists from Danish tertiary adrenal centres evaluated the 80 symptoms in the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), rated their relevance to GIAI, and suggested additional symptoms. Symptoms with mean relevance score ≥1 ('a little relevant') underwent final expert review before being explored in semi-structured patient interviews. Adult patients with GIAI for >6 months were recruited from endocrine outpatient clinics. Patients described symptom experiences, marked symptoms they recognized on the expert-generated list, and rated their significance for deciding to administer hydrocortisone stress doses. New symptoms were incorporated into subsequent interview rounds, continuing until symptom saturation. Eleven endocrinologists identified 17 relevant symptoms; three were excluded during final expert review, leaving 14 symptoms for patient evaluation. Thirty patients (median [IQR] GIAI duration 5.0 [3.2-9.6] years) participated and identified 14 additional symptoms. The most frequently reported symptoms were fatigue, feeling unwell, lethargy, difficulty concentrating, and nausea (all ≥60%). Symptoms with the highest significance ratings were vomiting, nausea, dizziness, hot flashes, fatigue, and feeling unwell (all >3, 'moderately important'). We identified 28 GIAI-relevant symptoms and characterized their frequency and patient-reported importance in guiding real-world dosing decisions, providing a patient-centred basis for symptom monitoring in GIAI.

PMID 43038356
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多aciclovir + hydrocortisone